Growth Metrics

Acadia Healthcare Company (ACHC) Cost of Revenue (2016 - 2026)

Acadia Healthcare Company (ACHC) has disclosed Cost of Revenue for 17 consecutive years, with $131.1 million as the latest value for Q1 2026.

  • For Q1 2026, Cost of Revenue rose 362.49% year-over-year to $131.1 million; the TTM value through Mar 2026 reached $326.7 million, up 14.12%, while the annual FY2025 figure was $118.0 million, 73.22% down from the prior year.
  • Cost of Revenue hit $131.1 million in Q1 2026 for Acadia Healthcare Company, up from $30.8 million in the prior quarter.
  • Across five years, Cost of Revenue topped out at $309.6 million in Q4 2023 and bottomed at $26.7 million in Q1 2024.
  • Average Cost of Revenue over 5 years is $99.6 million, with a median of $89.0 million recorded in 2022.
  • On a YoY basis, Cost of Revenue climbed as much as 382.15% in 2025 and fell as far as 73.91% in 2025.
  • Acadia Healthcare Company's Cost of Revenue stood at $275.0 million in 2022, then grew by 12.59% to $309.6 million in 2023, then plummeted by 61.92% to $117.9 million in 2024, then tumbled by 73.91% to $30.8 million in 2025, then skyrocketed by 326.12% to $131.1 million in 2026.
  • According to Business Quant data, Cost of Revenue over the past three periods came in at $131.1 million, $30.8 million, and $30.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.